{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T11:31:27Z","timestamp":1794483087442,"version":"4.9.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001734","name":"Copenhagen University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001734","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Fluids Barriers CNS"],"DOI":"10.1186\/s12987-025-00652-x","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T08:04:46Z","timestamp":1745481886000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Glucagon-like peptide-1 receptor modulates cerebrospinal fluid secretion and intracranial pressure in rats"],"prefix":"10.1186","volume":"22","author":[{"given":"Mette N.","family":"Jensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida M. E.","family":"Israelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan H.","family":"Wardman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis B.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel B.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trine L.","family":"Toft-Bertelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin F.","family":"Rath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Juul","family":"Holst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette M.","family":"Rosenkilde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7800-6600","authenticated-orcid":false,"given":"Nanna","family":"MacAulay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,24]]},"reference":[{"key":"652_CR1","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1152\/physrev.00004.2013","volume":"93","author":"HH Damkier","year":"2013","unstructured":"Damkier HH, Brown PD, Praetorius J. Cerebrospinal fluid secretion by the choroid plexus. Physiol Rev. 2013;93:1847\u201392.","journal-title":"Physiol Rev"},{"key":"652_CR2","first-page":"CD009706","volume":"5","author":"M Ziebell","year":"2013","unstructured":"Ziebell M, Wetterslev J, Tisell M, Gluud C, Juhler M. Flow-regulated versus differential pressure-regulated shunt valves for adult patients with normal pressure hydrocephalus. Cochrane Database Syst Rev. 2013;5:CD009706.","journal-title":"Cochrane Database Syst Rev"},{"key":"652_CR3","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1007\/s00134-019-05705-y","volume":"45","author":"M Smith","year":"2019","unstructured":"Smith M, Reddy U, Robba C, Sharma D, Citerio G. Acute ischaemic stroke: challenges for the intensivist. Intensive Care Med. 2019;45:1177\u201389.","journal-title":"Intensive Care Med"},{"key":"652_CR4","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1007\/s10620-022-07519-3","volume":"67","author":"JJ Holst","year":"2022","unstructured":"Holst JJ. Discovery of the GI effects of GLP-1: an historical perspective. Dig Dis Sci. 2022;67:2716\u201320.","journal-title":"Dig Dis Sci"},{"key":"652_CR5","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/BF01316798","volume":"38","author":"A Wettergren","year":"1993","unstructured":"Wettergren A, Schjoldager B, Mortensen PE, Myhre J, Christiansen J, Holst JJ. Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man. Dig Dis Sci. 1993;38:665\u201373.","journal-title":"Dig Dis Sci"},{"key":"652_CR6","doi-asserted-by":"publisher","first-page":"R465","DOI":"10.1152\/ajpregu.00179.2014","volume":"307","author":"AL Alhadeff","year":"2014","unstructured":"Alhadeff AL, Grill HJ. Hindbrain nucleus tractus solitarius glucagon-like peptide-1 receptor signaling reduces appetitive and motivational aspects of feeding. Am J Physiol Regul Integr Comp Physiol. 2014;307:R465\u201370.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"652_CR7","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/S0140-6736(09)61375-1","volume":"374","author":"A Astrup","year":"2009","unstructured":"Astrup A, R\u00f6ssner S, Van Gaal L, Rissanen A, Niskanen L, Al Hakim M, Madsen J, Rasmussen MF, Lean ME. Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study. Lancet. 2009;374:1606\u201316.","journal-title":"Lancet"},{"key":"652_CR8","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1172\/JCI990","volume":"101","author":"A Flint","year":"1998","unstructured":"Flint A, Raben A, Astrup A, Holst JJ. Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. J Clin Invest. 1998;101:515\u201320.","journal-title":"J Clin Invest"},{"key":"652_CR9","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S0306-4522(96)00434-4","volume":"77","author":"PJ Larsen","year":"1997","unstructured":"Larsen PJ, Tang-Christensen M, Holst JJ, Orskov C. Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem. Neuroscience. 1997;77:257\u201370.","journal-title":"Neuroscience"},{"key":"652_CR10","first-page":"R848","volume":"271","author":"M Tang-Christensen","year":"1996","unstructured":"Tang-Christensen M, Larsen PJ, G\u00f6ke R, Fink-Jensen A, Jessop DS, M\u00f8ller M, Sheikh SP. Central administration of GLP-1-(7\u201336) amide inhibits food and water intake in rats. Am J Physiol. 1996;271:R848\u201356.","journal-title":"Am J Physiol"},{"key":"652_CR11","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/379069a0","volume":"379","author":"MD Turton","year":"1996","unstructured":"Turton MD, O\u2019Shea D, Gunn I, Beak SA, Edwards CM, Meeran K, Choi SJ, Taylor GM, Heath MM, Lambert PD, Wilding JP, Smith DM, Ghatei MA, Herbert J, Bloom SR. A role for glucagon-like peptide-1 in the central regulation of feeding. Nature. 1996;379:69\u201372.","journal-title":"Nature"},{"key":"652_CR12","doi-asserted-by":"publisher","first-page":"F1647","DOI":"10.1152\/ajprenal.00082.2009","volume":"297","author":"LR Carraro-Lacroix","year":"2009","unstructured":"Carraro-Lacroix LR, Malnic G, Girardi AC. Regulation of Na+\/H\u2009+\u2009exchanger NHE3 by glucagon-like peptide 1 receptor agonist exendin-4 in renal proximal tubule cells. Am J Physiol Ren Physiol. 2009;297:F1647\u201355.","journal-title":"Am J Physiol Ren Physiol"},{"key":"652_CR13","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrneph.2013.272","volume":"10","author":"MH Muskiet","year":"2014","unstructured":"Muskiet MH, Smits MM, Morsink LM, Diamant M. The gut-renal axis: do incretin-based agents confer renoprotection in diabetes? Nat Rev Nephrol. 2014;10:88\u2013103.","journal-title":"Nat Rev Nephrol"},{"key":"652_CR14","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/nrneph.2017.123","volume":"13","author":"MHA Muskiet","year":"2017","unstructured":"Muskiet MHA, Tonneijck L, Smits MM, van Baar MJB, Kramer MHH, Hoorn EJ, Joles JA, van Raalte DH. GLP-1 and the kidney: from physiology to Pharmacology and outcomes in diabetes. Nat Rev Nephrol. 2017;13:605\u201328.","journal-title":"Nat Rev Nephrol"},{"key":"652_CR15","doi-asserted-by":"publisher","first-page":"807","DOI":"10.4239\/wjd.v6.i6.807","volume":"6","author":"EM Candeias","year":"2015","unstructured":"Candeias EM, Sebasti\u00e3o IC, Cardoso SM, Correia SC, Carvalho CI, Pl\u00e1cido AI, Santos MS, Oliveira CR, Moreira PI, Duarte AI. Gut-brain connection: the neuroprotective effects of the anti-diabetic drug liraglutide. World J Diabetes. 2015;6:807\u201327.","journal-title":"World J Diabetes"},{"key":"652_CR16","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1007\/s00125-023-05906-7","volume":"66","author":"DJ Drucker","year":"2023","unstructured":"Drucker DJ, Holst JJ. The expanding incretin universe: from basic biology to clinical translation. Diabetologia. 2023;66:1765\u201379.","journal-title":"Diabetologia"},{"key":"652_CR17","doi-asserted-by":"publisher","first-page":"3501","DOI":"10.1111\/dom.15693","volume":"26","author":"JB Winther","year":"2024","unstructured":"Winther JB, Holst JJ. Glucagon agonism in the treatment of metabolic diseases including type 2 diabetes mellitus and obesity. Diabetes Obes Metab. 2024;26:3501\u201312.","journal-title":"Diabetes Obes Metab"},{"key":"652_CR18","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12933-025-02607-w","volume":"24","author":"D Hullon","year":"2025","unstructured":"Hullon D, Subeh GK, Volkova Y, Janiec K, Trach A, Mnevets R. The role of glucagon-like peptide-1 receptor (GLP-1R) agonists in enhancing endothelial function: a potential avenue for improving heart failure with preserved ejection fraction (HFpEF). Cardiovasc Diabetol. 2025;24:70.","journal-title":"Cardiovasc Diabetol"},{"key":"652_CR19","doi-asserted-by":"publisher","first-page":"807","DOI":"10.4239\/wjd.v6.i6.807","volume":"6","author":"EM Candeias","year":"2015","unstructured":"Candeias EM, Sebastiao IC, Cardoso SM, Correia SC, Carvalho CI, Placido AI, Santos MS, Oliveira CR, Moreira PI, Duarte AI. Gut-brain connection: the neuroprotective effects of the anti-diabetic drug liraglutide. World J Diabetes. 2015;6:807\u201327.","journal-title":"World J Diabetes"},{"key":"652_CR20","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12987-022-00335-x","volume":"19","author":"SN Andreassen","year":"2022","unstructured":"Andreassen SN, Toft-Bertelsen TL, Wardman JH, Villadsen R, MacAulay N. Transcriptional profiling of transport mechanisms and regulatory pathways in rat choroid plexus. Fluids Barriers CNS. 2022;19:44.","journal-title":"Fluids Barriers CNS"},{"key":"652_CR21","doi-asserted-by":"crossref","unstructured":"Botfield HF, Uldall MS, Westgate CSJ, Mitchell JL, Hagen SM, Gonzalez AM, Hodson DJ, Jensen RH, Sinclair AJ. A glucagon-like peptide-1 receptor agonist reduces intracranial pressure in a rat model of hydrocephalus. Sci Transl Med. 2017;9(404):eaan0972.","DOI":"10.1126\/scitranslmed.aan0972"},{"key":"652_CR22","doi-asserted-by":"crossref","unstructured":"Andersen DB, Grunddal KV, Pedersen J, Kuhre RE, Lund ML, Holst JJ, et al. Using a reporter mouse to map known and novel sites of GLP-1 receptor expression in peripheral tissues of male mice. Endocrinology. 2021;162(3):bqaa246.","DOI":"10.1210\/endocr\/bqaa246"},{"key":"652_CR23","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s00210-020-01867-5","volume":"393","author":"LP Gea","year":"2020","unstructured":"Gea LP, da Rosa ED, Panizzutti BS, de Aguiar EZ, de Oliveira LF, Ferrari P, Piato A, Gomez R, Colombo R, Rosa AR. Reduction of hippocampal IL-6 levels in LPS-injected rats following acute exendin-4 treatment. Naunyn Schmiedebergs Arch Pharmacol. 2020;393:1303\u201311.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"652_CR24","doi-asserted-by":"publisher","first-page":"4059","DOI":"10.1210\/en.2007-1743","volume":"149","author":"MR Hayes","year":"2008","unstructured":"Hayes MR, Skibicka KP, Grill HJ. Caudal brainstem processing is sufficient for behavioral, sympathetic, and parasympathetic responses driven by peripheral and hindbrain glucagon-like-peptide-1 receptor stimulation. Endocrinology. 2008;149:4059\u201368.","journal-title":"Endocrinology"},{"key":"652_CR25","doi-asserted-by":"publisher","first-page":"e103114","DOI":"10.1371\/journal.pone.0103114","volume":"9","author":"V Darsalia","year":"2014","unstructured":"Darsalia V, Hua S, Larsson M, Mallard C, Nathanson D, Nystrom T, Sjoholm A, Johansson ME, Patrone C. Exendin-4 reduces ischemic brain injury in normal and aged type 2 diabetic mice and promotes microglial M2 polarization. PLoS ONE. 2014;9:e103114.","journal-title":"PLoS ONE"},{"key":"652_CR26","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1111\/bph.15524","volume":"179","author":"IL Augestad","year":"2022","unstructured":"Augestad IL, Dekens D, Karampatsi D, Elabi O, Zabala A, Pintana H, Larsson M, Nystrom T, Paul G, Darsalia V, Patrone C. Normalisation of glucose metabolism by exendin-4 in the chronic phase after stroke promotes functional recovery in male diabetic mice. Br J Pharmacol. 2022;179:677\u201394.","journal-title":"Br J Pharmacol"},{"key":"652_CR27","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1093\/brain\/awad003","volume":"146","author":"JL Mitchell","year":"2023","unstructured":"Mitchell JL, Lyons HS, Walker JK, Yiangou A, Grech O, Alimajstorovic Z, Greig NH, Li Y, Tsermoulas G, Brock K, Mollan SP, Sinclair AJ. The effect of GLP-1RA exenatide on idiopathic intracranial hypertension: a randomized clinical trial. Brain. 2023;146:1821\u201330.","journal-title":"Brain"},{"key":"652_CR28","doi-asserted-by":"publisher","first-page":"4812","DOI":"10.1523\/JNEUROSCI.6326-11.2012","volume":"32","author":"SL Dickson","year":"2012","unstructured":"Dickson SL, Shirazi RH, Hansson C, Bergquist F, Nissbrandt H, Skibicka KP. The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors. J Neurosci. 2012;32:4812\u201320.","journal-title":"J Neurosci"},{"key":"652_CR29","doi-asserted-by":"crossref","unstructured":"Ahren B. Contribution of GIP and GLP-1 to the insulin response to oral administration of glucose in female mice. Biomedicines. 2023;11(2):591.","DOI":"10.3390\/biomedicines11020591"},{"key":"652_CR30","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.2337\/db06-0307","volume":"55","author":"H Sorensen","year":"2006","unstructured":"Sorensen H, Winzell MS, Brand CL, Fosgerau K, Gelling RW, Nishimura E, Ahren B. Glucagon receptor knockout mice display increased insulin sensitivity and impaired beta-cell function. Diabetes. 2006;55:3463\u20139.","journal-title":"Diabetes"},{"key":"652_CR31","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1111\/bph.13384","volume":"173","author":"LS Hansen","year":"2016","unstructured":"Hansen LS, Sparre-Ulrich AH, Christensen M, Knop FK, Hartmann B, Holst JJ, Rosenkilde MM. N-terminally and C-terminally truncated forms of glucose-dependent insulinotropic polypeptide are high-affinity competitive antagonists of the human GIP receptor. Br J Pharmacol. 2016;173:826\u201338.","journal-title":"Br J Pharmacol"},{"key":"652_CR32","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.regpep.2012.08.016","volume":"179","author":"H Kissow","year":"2012","unstructured":"Kissow H, Hartmann B, Holst JJ, Viby NE, Hansen LS, Rosenkilde MM, Hare KJ, Poulsen SS. Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 Inhibition does not accelerate neoplasia in carcinogen treated mice. Regul Pept. 2012;179:91\u2013100.","journal-title":"Regul Pept"},{"key":"652_CR33","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12987-023-00451-2","volume":"20","author":"AB Steffensen","year":"2023","unstructured":"Steffensen AB, Edelbo BL, Barbuskaite D, Andreassen SN, Olsen MH, M\u00f8ller K, MacAulay N. Nocturnal increase in cerebrospinal fluid secretion as a regulator of intracranial pressure. Fluids Barriers CNS. 2023;20:49.","journal-title":"Fluids Barriers CNS"},{"key":"652_CR34","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/dom.13078","volume":"20","author":"CM Craig","year":"2018","unstructured":"Craig CM, Liu LF, Nguyen T, Price C, Bingham J, McLaughlin TL. Efficacy and pharmacokinetics of subcutaneous Exendin (9\u201339) in patients with post-bariatric hypoglycaemia. Diabetes Obes Metab. 2018;20:352\u201361.","journal-title":"Diabetes Obes Metab"},{"key":"652_CR35","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1002\/ddr.1195","volume":"53","author":"D Parkes","year":"2001","unstructured":"Parkes D, Jodka C, Smith P, Nayak S, Rinehart L, Gingerich R, Chen K, Young A. Pharmacokinetic actions of exendin-4 in the rat: comparison with glucagon-like peptide-1. Drug Develop Res. 2001;53:260\u201367.","journal-title":"Drug Develop Res"},{"key":"652_CR36","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12987-022-00358-4","volume":"19","author":"EK Oernbo","year":"2022","unstructured":"Oernbo EK, Steffensen AB, Razzaghi Khamesi P, Toft-Bertelsen TL, Barbuskaite D, Vilhardt F, Gerkau NJ, Tritsaris K, Simonsen AH, Lolansen SD, Andreassen SN, Hasselbalch SG, Zeuthen T, Rose CR, Kurtcuoglu V, MacAulay N. Membrane transporters control cerebrospinal fluid formation independently of conventional osmosis to modulate intracranial pressure. Fluids Barriers CNS. 2022;19:65.","journal-title":"Fluids Barriers CNS"},{"key":"652_CR37","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1038\/s41467-018-04677-9","volume":"9","author":"AB Steffensen","year":"2018","unstructured":"Steffensen AB, Oernbo EK, Stoica A, Gerkau NJ, Barbuskaite D, Tritsaris K, Rose CR, MacAulay N. Cotransporter-mediated water transport underlying cerebrospinal fluid formation. Nat Commun. 2018;9:2167.","journal-title":"Nat Commun"},{"key":"652_CR38","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0167-0115(96)00113-9","volume":"67","author":"JM Barragan","year":"1996","unstructured":"Barragan JM, Rodriguez RE, Eng J, Blazquez E. Interactions of exendin-(9\u201339) with the effects of glucagon-like peptide-1-(7\u201336) amide and of exendin-4 on arterial blood pressure and heart rate in rats. Regul Pept. 1996;67:63\u20138.","journal-title":"Regul Pept"},{"key":"652_CR39","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1016\/j.jtcvs.2017.10.085","volume":"155","author":"JN Roan","year":"2018","unstructured":"Roan JN, Hsu CH, Fang SY, Tsai HW, Luo CY, Huang CC, Lam CF. Exendin-4 improves cardiovascular function and survival in flow-induced pulmonary hypertension. J Thorac Cardiovasc Surg. 2018;155:1661\u201369. e4.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"652_CR40","doi-asserted-by":"publisher","first-page":"4503","DOI":"10.1210\/en.2013-1666","volume":"154","author":"NE Viby","year":"2013","unstructured":"Viby NE, Isidor MS, Buggeskov KB, Poulsen SS, Hansen JB, Kissow H. Glucagon-like peptide-1 (GLP-1) reduces mortality and improves lung function in a model of experimental obstructive lung disease in female mice. Endocrinology. 2013;154:4503\u201311.","journal-title":"Endocrinology"},{"key":"652_CR41","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12987-022-00323-1","volume":"19","author":"N MacAulay","year":"2022","unstructured":"MacAulay N, Keep RF, Zeuthen T. Cerebrospinal fluid production by the choroid plexus: a century of barrier research revisited. Fluids Barriers CNS. 2022;19:26.","journal-title":"Fluids Barriers CNS"},{"key":"652_CR42","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41583-021-00454-8","volume":"22","author":"N MacAulay","year":"2021","unstructured":"MacAulay N. Molecular mechanisms of brain water transport. Nat Rev Neurosci. 2021;22:326\u201344.","journal-title":"Nat Rev Neurosci"},{"key":"652_CR43","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1124\/pr.115.011395","volume":"68","author":"C Graaf","year":"2016","unstructured":"Graaf C, Donnelly D, Wootten D, Lau J, Sexton PM, Miller LJ, Ahn JM, Liao J, Fletcher MM, Yang D, Brown AJ, Zhou C, Deng J, Wang MW. Glucagon-Like Peptide-1 and its class B G Protein-Coupled receptors: A long March to therapeutic successes. Pharmacol Rev. 2016;68:954\u20131013.","journal-title":"Pharmacol Rev"},{"key":"652_CR44","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1016\/j.cell.2016.05.023","volume":"165","author":"D Wootten","year":"2016","unstructured":"Wootten D, Reynolds CA, Smith KJ, Mobarec JC, Koole C, Savage EE, Pabreja K, Simms J, Sridhar R, Furness SGB, Liu M, Thompson PE, Miller LJ, Christopoulos A, Sexton PM. The extracellular surface of the GLP-1 receptor is a molecular trigger for biased agonism. Cell. 2016;165:1632\u201343.","journal-title":"Cell"},{"key":"652_CR45","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1126\/science.193189","volume":"196","author":"MH Epstein","year":"1977","unstructured":"Epstein MH, Feldman AM, Brusilow SW. Cerebrospinal fluid production: stimulation by cholera toxin. Science. 1977;196:1012\u20133.","journal-title":"Science"},{"key":"652_CR46","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12987-022-00361-9","volume":"19","author":"TL Toft-Bertelsen","year":"2022","unstructured":"Toft-Bertelsen TL, Barbuskaite D, Heerfordt EK, Lolansen SD, Andreassen SN, Rostgaard N, Olsen MH, Norager NH, Capion T, Rath MF, Juhler M, MacAulay N. Lysophosphatidic acid as a CSF lipid in posthemorrhagic hydrocephalus that drives CSF accumulation via TRPV4-induced hyperactivation of NKCC1. Fluids Barriers CNS. 2022;19:69.","journal-title":"Fluids Barriers CNS"},{"key":"652_CR47","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12987-023-00436-1","volume":"20","author":"JH Wardman","year":"2023","unstructured":"Wardman JH, Jensen MN, Andreassen SN, Styrishave B, Wilhjelm JE, Sinclair AJ, MacAulay N. Modelling idiopathic intracranial hypertension in rats: contributions of high fat diet and testosterone to intracranial pressure and cerebrospinal fluid production. Fluids Barriers CNS. 2023;20:44.","journal-title":"Fluids Barriers CNS"},{"key":"652_CR48","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/bja\/71.2.267","volume":"71","author":"L Papazian","year":"1993","unstructured":"Papazian L, Albanese J, Thirion X, Perrin G, Durbec O, Martin C. Effect of bolus doses of Midazolam on intracranial pressure and cerebral perfusion pressure in patients with severe head injury. Br J Anaesth. 1993;71:267\u201371.","journal-title":"Br J Anaesth"},{"key":"652_CR49","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0022-3565(25)28503-2","volume":"172","author":"TH Maren","year":"1970","unstructured":"Maren TH, Broder LE. The role of carbonic anhydrase in anion secretion into cerebrospinal fluid. J Pharmacol Exp Ther. 1970;172:197\u2013202.","journal-title":"J Pharmacol Exp Ther"},{"key":"652_CR50","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/0304-3940(92)90253-4","volume":"143","author":"QS Deng","year":"1992","unstructured":"Deng QS, Johanson CE. Cyclic AMP alteration of chloride transport into the choroid plexus-cerebrospinal fluid system. Neurosci Lett. 1992;143:146\u201350.","journal-title":"Neurosci Lett"},{"key":"652_CR51","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1242\/jeb.039644","volume":"213","author":"AW Flemmer","year":"2010","unstructured":"Flemmer AW, Monette MY, Djurisic M, Dowd B, Darman R, Gimenez I, Forbush B. Phosphorylation state of the Na+-K+-Cl- cotransporter (NKCC1) in the gills of Atlantic killifish (Fundulus heteroclitus) during acclimation to water of varying salinity. J Exp Biol. 2010;213:1558\u201366.","journal-title":"J Exp Biol"},{"key":"652_CR52","doi-asserted-by":"publisher","first-page":"C817","DOI":"10.1152\/ajpcell.00352.2001","volume":"282","author":"K Kurihara","year":"2002","unstructured":"Kurihara K, Nakanishi N, Moore-Hoon ML, Turner RJ. Phosphorylation of the salivary Na(+)-K(+)-2Cl(-) cotransporter. Am J Physiol Cell Physiol. 2002;282:C817\u201323.","journal-title":"Am J Physiol Cell Physiol"},{"key":"652_CR53","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1177\/15353702231188072","volume":"248","author":"L Liu","year":"2023","unstructured":"Liu L, Bulla LA. Jr. Cell death signaling in Anopheles Gambiae initiated by Bacillus Thuringiensis Cry4B toxin involves Na(+)\/K(+) ATPase. Exp Biol Med. 2023;248:1191\u2013205.","journal-title":"Exp Biol Med"},{"key":"652_CR54","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41582-023-00893-0","volume":"19","author":"A Yiangou","year":"2023","unstructured":"Yiangou A, Mollan SP, Sinclair AJ. Idiopathic intracranial hypertension: a step change in Understanding the disease mechanisms. Nat Rev Neurol. 2023;19:769\u201385.","journal-title":"Nat Rev Neurol"},{"key":"652_CR55","doi-asserted-by":"crossref","unstructured":"Haddad F, Dokmak G, Bader M, Karaman R. A comprehensive review on weight loss associated with Anti-Diabetic medications. Life (Basel). 2023;13(4):1012.","DOI":"10.3390\/life13041012"},{"key":"652_CR56","doi-asserted-by":"crossref","unstructured":"Sun F, Chai S, Li L, Yu K, Yang Z, Wu S, Zhang Y, Ji L, Zhan S. Effects of glucagon-like peptide-1 receptor agonists on weight loss in patients with type 2 diabetes: a systematic review and network meta-analysis. J Diabetes Res. 2015; 157201.","DOI":"10.1155\/2015\/157201"},{"key":"652_CR57","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1001\/jamaneurol.2021.0659","volume":"78","author":"SP Mollan","year":"2021","unstructured":"Mollan SP, Mitchell JL, Ottridge RS, Aguiar M, Yiangou A, Alimajstorovic Z, Cartwright DM, Grech O, Lavery GG, Westgate CSJ, Vijay V, Scotton W, Wakerley BR, Matthews TD, Ansons A, Hickman SJ, Benzimra J, Rick C, Singhal R, Tahrani AA, Brock K, Frew E, Sinclair AJ. Effectiveness of bariatric surgery vs community weight management intervention for the treatment of idiopathic intracranial hypertension: A randomized clinical trial. JAMA Neurol. 2021;78:678\u201386.","journal-title":"JAMA Neurol"},{"key":"652_CR58","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1001\/jamaophthalmol.2024.2296","volume":"142","author":"JT Hathaway","year":"2024","unstructured":"Hathaway JT, Shah MP, Hathaway DB, Zekavat SM, Krasniqi D, Gittinger JW Jr., Cestari D, Mallery R, Abbasi B, Bouffard M, Chwalisz BK, Estrela T, Rizzo JF. 3rd. Risk of nonarteritic anterior ischemic optic neuropathy in patients prescribed semaglutide. JAMA Ophthalmol. 2024;142:732\u201339.","journal-title":"JAMA Ophthalmol"},{"key":"652_CR59","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.survophthal.2021.11.007","volume":"67","author":"JS Xie","year":"2022","unstructured":"Xie JS, Donaldson L, Margolin E, Papilledema. A review of etiology, pathophysiology, diagnosis, and management. Surv Ophthalmol. 2022;67:1135\u201359.","journal-title":"Surv Ophthalmol"},{"key":"652_CR60","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.preteyeres.2015.10.001","volume":"50","author":"SS Hayreh","year":"2016","unstructured":"Hayreh SS. Pathogenesis of optic disc edema in Raised intracranial pressure. Prog Retin Eye Res. 2016;50:108\u201344.","journal-title":"Prog Retin Eye Res"}],"container-title":["Fluids and Barriers of the CNS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-025-00652-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12987-025-00652-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12987-025-00652-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T09:03:53Z","timestamp":1745485433000},"score":1,"resource":{"primary":{"URL":"https:\/\/fluidsbarrierscns.biomedcentral.com\/articles\/10.1186\/s12987-025-00652-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["652"],"URL":"https:\/\/doi.org\/10.1186\/s12987-025-00652-x","relation":{},"ISSN":["2045-8118"],"issn-type":[{"value":"2045-8118","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,24]]},"assertion":[{"value":"10 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal experiments were in compliance with the European Community Council Directive 2010\/63\/EU on the Protection of Animals used for Scientific Purposes. It was approved by the Danish Animal Experiments Inspectorate with permission no. 2021-15-0201-00867 and 2018-15-0201-01397).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41"}}